Xeloda 150 mg film-coated tablets clinical trials
3 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic confirmatory (Phase III)
BALLAD Belgium - A trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma. The Belgian component of the Global Ballad pooled data analysis.
This study, called BALLAD, is looking into whether extra chemotherapy after surgery can help people with a type of bowel cancer called small bowel adenocarcinoma. It's a big study involving different countries, and explores how long people live without the cancer coming back, and other important health measures.
For: small bowel adenocarcinomaBelgium - AuthorisedPhase II and Phase III (Integrated)
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for resectable colorectal peritoneal metastases: a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6).
This study compares two ways to treat bowel cancer that has spread to the lining of the tummy. It looks at whether adding chemotherapy before surgery helps people live longer compared to surgery alone. The aim is to find the best treatment plan.
For: Resectable peritoneal metastases of a colorectal originBelgium · Netherlands - Ongoing, recruitingTherapeutic exploratory (Phase II)
FFCD 1605- OPTIPRIME: A phase II study evaluating FOLFOX + panitumumab according to a ‘stop-and-go’ strategy with a reintroduction loop after progression on fluoropyrimidine as maintenance treatment, as the first line in patients with metastatic colorectal adenocarcinoma without a RAS mutation
This study is looking at a new way to treat bowel cancer that has spread. It combines existing medications, panitumumab and FOLFOX, using a 'stop-and-go' approach. The aim is to see how long the treatment keeps the cancer under control before it grows again, for patients without a specific gene change (RAS mutation).
For: metastatic colorectal adenocarcinomaFrance · Belgium